血液公司
DE ˙ DB ˙ US4050241003
€59.00 ↑3.00 (5.36%)
2026-06-04
分享價格
SecurityDE:HAZ / Haemonetics Corporation
InstitutionUBS Group AG
Latest Disclosed Ownership526,617 shares
Latest Disclosed Value $ 29,680,134
UBS Group AG ownership in HAZ / Haemonetics Corporation

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 526,617 shares of Haemonetics Corporation (DE:HAZ) valued at $25,277,616 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 539,677 shares of Haemonetics Corporation. This represents a change in shares of -2.42% during the quarter. The current value of the position is $31,070,403 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (HAZ) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HAZ / Haemonetics Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 526,617 -13,060 -2.42 29,680 -31.38 0.0045
2026-01-29 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 539,677 -912,894 -62.85 43,255 -38.90 0.0070
2025-11-13 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,452,571 582,782 67.00 70,798 9.10 0.0111
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 869,789 453,692 109.04 64,895 145.42 0.0112
2025-05-13 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 416,097 223,585 116.14 26,443 75.92 0.0049
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 192,512 168,466 700.60 15,031 678.00 0.0028
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 24,046 5,240 27.86 1,933 24.24 0.0004
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 18,806 -39,308 -67.64 1,556 -68.65 0.0004
2024-05-13 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 58,114 -13,973 -19.38 4,960 -19.53 0.0012
2024-02-09 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 72,087 27,618 62.11 6,164 54.76 0.0018
2023-11-09 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 44,469 -25,399 -36.35 3,984 -33.04 0.0014
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 69,868 11,056 18.80 5,949 22.24 0.0020
2023-05-12 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 58,812 15,563 35.98 4,867 43.08 0.0018
2023-02-08 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 43,249 37,274 623.83 3,402 669.46 0.0013
2022-11-10 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 5,975 919 18.18 442 34.35 0.0002
2022-08-10 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,056 -14,800 -74.54 329 -73.81 0.0001
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 19,856 -13,583 -40.62 1,256 -29.20 0.0004
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 33,439 30,020 878.03 1,774 636.10 0.0005
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 3,419 -275 -7.44 241 -2.03 0.0001
2021-08-13 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 3,694 -14,433 -79.62 246 -87.77 0.0001
2021-05-12 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 18,127 -5,276 -22.54 2,012 -27.60 0.0007
2021-02-11 2020-12-31 13F HAEMONETICS COM 405024100 23,403 -13,209 -36.08 2,779 -12.99 0.0009
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 36,612 30,890 539.85 3,194 523.83 0.0012
2020-07-31 2020-06-30 13F HAEMONETICS COM 405024100 5,722 -5,792 -50.30 512 -55.36 0.0002
2020-05-01 2020-03-31 13F HAEMONETICS COM 405024100 11,514 -104,784 -90.10 1,147 -91.42 0.0005
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 116,298 60,904 109.95 13,362 91.24 0.0046
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 55,394 26,586 92.29 6,987 101.59 0.0027
2019-08-14 2019-06-30 13F HAEMONETICS COM 405024100 28,808 -10,210 -26.17 3,466 1.55 0.0013
2019-05-14 2019-03-31 13F HAEMONETICS COM 405024100 39,018 -20,231 -34.15 3,413 -42.43 0.0014
2019-02-14 2018-12-31 13F HAEMONETICS COM 405024100 59,249 -2,484 -4.02 5,928 -16.20 0.0027
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 61,733 26,961 77.54 7,074 126.88 0.0028
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 34,772 20,376 141.54 3,118 196.11 0.0014
2018-05-15 2018-03-31 13F HAEMONETICS COM 405024100 14,396 2,185 17.89 1,053 48.52 0.0005
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 12,211 -4,085 -25.07 709 -3.01 0.0003
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 16,296 4,814 41.93 731 61.37 0.0003
2017-11-14 2017-06-30 13F/A-1 HAEMONETICS COM 405024100 11,482 -1,230 -9.68 453 -12.21 0.0002
2017-08-14 2017-06-30 13F HAEMONETICS COM 405024100 11,482 -1,230 453
2017-11-14 2017-03-31 13F/A-1 HAEMONETICS COM 405024100 12,712 -6,340 -33.28 516 -32.64 0.0003
2017-05-12 2017-03-31 13F HAEMONETICS COM 405024100 12,712 -6,340 516
2017-02-14 2016-12-31 13F HAEMONETICS COM 405024100 19,052 7,246 61.38 766 79.39 0.0004
2016-11-14 2016-09-30 13F HAEMONETICS COM 405024100 11,806 -1,829 -13.41 427 7.83 0.0003
2016-08-12 2016-06-30 13F HAEMONETICS COM 405024100 13,635 3,534 34.99 396 12.18 0.0002
2016-05-12 2016-03-31 13F HAEMONETICS COM 405024100 10,101 3,287 48.24 353 60.45 0.0002
2016-02-16 2015-12-31 13F HAEMONETICS COM 405024100 6,814 -3,401 -33.29 220 -33.33 0.0001
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 10,215 1,895 22.78 330 -4.07 0.0002
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 8,320 2,992 56.16 344 43.93 0.0002
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 5,328 1,811 51.49 239 81.06 0.0002
2015-02-17 2014-12-31 13F HAEMONETICS COM 405024100 3,517 3,517 132 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS COM Call 18,000 1,271 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-01-29 2025-12-31 13F HAEMONETICS CORP MASS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-13 2025-09-30 13F HAEMONETICS CORP MASS COM Put 77,500 3,777 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.